HARP - Harpoon Therapeutics Inc. (HARP) CEO Gerald McMahon on Q4 2020 Results - Earnings Call Transcript
Harpoon Therapeutics, Inc. (HARP) Q4 2020 Earnings Conference Call March 10, 2021, 04:30 PM ET Company Participants Gerald McMahon - President and CEO Georgia Erbez - CFO Natalie Sacks - Chief Medical Officer Holger Wesche - Chief Scientific Officer Conference Call Participants Jonathan Chang - SVB Leerink Tyler Van Buren - Piper Sandler Yigal Nochomovitz - Citigroup Asthika Goonewardene - Truist Securities Zegbeh Jallah - ROTH Capital Partners Arlinda Lee - Canaccord. Colleen Kusy - Baird Robert Driscoll - Wedbush Securities Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Harpoon Therapeutics 4Q 2020 Financial Results and Corporate Update Conference Call. At this time all participants are in listen-only mode. Please be advised that today’s conference may be recorded. [Operator Instructions] On the call today from Harpoon are Gerry McMahon, President and Chief Executive Officer; Georgia Erbez, Chief Financial Officer, Georgia Erbez, Chief Financial Officer,
For further details see:
Harpoon Therapeutics, Inc. (HARP) CEO Gerald McMahon on Q4 2020 Results - Earnings Call Transcript